Bigul

Appointment of Director

Lyka Labs Ltd has informed BSE that at the Board Meeting held on March 29, 2012, the Board of Directors have appointed Mr. V. Shanbhag as Director of the Company.
03-04-2012
Bigul

Outcome of Board Meeting

Lyka Labs Ltd has informed BSE that the Board of the Directors of the Company at its meeting held on March 29, 2012, the Board has deferred transfer / sale of Company's R&D; Division to its wholly owned subsidiary Company.
30-03-2012
Bigul

Board Meeting on March 29, 2012

Lyka Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 29, 2012 to consider transfer / sale of the Company's R&D; Centre to its wholly owned subsidiary Company.
26-03-2012
Bigul

Financial Results for Dec 31, 2011

Lyka Labs Ltd has informed BSE about the Financial Results for the period ended December 31, 2011.
14-02-2012
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Nehal N Gandhi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE:
08-02-2012
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Kunal N Gandhi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEName of the Target Company (TC) : Lyka Labs LtdName of the Promoter(s) on whose shares encumbrance was created/ invoked/ released : Kunal N GandhiDate of reporting : December 28, 2011...
02-01-2012
Bigul

Updates - Agreement for Transfer of Know How/ Technology

Lyka Labs Ltd has informed BSE that the Company has recently entered into a Technology Transfer Agreement with a Pharma Company based in Republic of Turkey for a lyophilized formulation, for a. consideration of US $ 2,50,000 and Royalty for five years.
30-12-2011
Bigul

Technical Assistance Agreement

Lyka Labs Ltd has informed BSE that the Company has entered into a "Technical Assistance Agreement" for "Lyophilized Formulations" with a Company based at Indonesia.
25-11-2011
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Nehal N Gandhi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEName of the Target Company (TC) : Lyka Labs LtdName of the Promoter(s) on whose shares encumbrance was created/ invoked/ released : Nehal N GandhiDate of reporting : November 04, 2011...
22-11-2011
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Narendra I Gandhi (HUF) has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEName of the Target Company (TC) : Lyka Labs LtdName of the Promoter(s) on whose shares encumbrance was created/ invoked/ released : Narendra I Gandhi (HUF)Date of reporting : November 17, 2011...
22-11-2011
Next Page
Close

Let's Open Free Demat Account